Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 13/20 | 0.36 |
| ▸ | ADH1A | P07327 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10041305 | 0.91 | DRD2 (0.47) | DRD2DRD3CYP1A2BCHEADH1A | |
| SCHEMBL10324879 | 0.86 | CYP1A2 (0.50) | DRD2DRD3CYP1A2BCHEADH1A | |
| SCHEMBL10324987 | 0.84 | CYP1A2 (0.54) | DRD2DRD3CYP1A2BCHEADH1A | |
| SCHEMBL3315286 | 0.84 | CYP1A2 (0.46) | DRD2DRD3CYP1A2BCHESIGMAR1 | |
| SCHEMBL28250076 | 0.82 | CYP1A2 (0.50) | DRD3CYP1A2BCHESIGMAR1ACHE | |
| SCHEMBL10325779 | 0.82 | CYP1A2 (0.50) | DRD3CYP1A2BCHESIGMAR1ACHE | |
| SCHEMBL25565980 | 0.80 | NCF1 (0.41) | DRD2DRD3BCHEACHE | |
| SCHEMBL12319143 | 0.80 | CYP1A2 (0.45) | DRD2DRD3CYP1A2BCHEADH1A | |
| SCHEMBL16299333 | 0.80 | OPRM1 (0.40) | DRD2DRD3CYP1A2ADH1AADH1C | |
| SCHEMBL25739068 | 0.79 | DRD2 (0.40) | DRD2DRD3CYP1A2BCHEADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054766-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | MITO BIOPHARMA, LLC (US) | 2024-03-14 | — | — | WO | disclosed |